Novavax Inc (NASDAQ:NVAX)
| 84.58 Delayed Data As of Jan 21 |  -5.78 / -6.40%Today’s Change | 84.55 Today|||52-Week Range 331.68 | -40.88% Year-to-Date |
Latest NVAX News | Press Releases
| 1 Green Flag for Novavax in 2022, and 1 Red Flag 6:00am / MotleyFool.com - Paid Partner Content | Why BioNTech, Moderna, Novavax, and Ocugen Stocks Are Plunging This Week Jan 20 / MotleyFool.com - Paid Partner Content |
| The Worst Mistake Moderna Investors Can Make in 2022 Jan 22 / MotleyFool.com - Paid Partner Content | Could Novavax Go Parabolic? Jan 19 / MotleyFool.com - Paid Partner Content |
| 2 Growth Stocks That Could Take Off in February Jan 21 / MotleyFool.com - Paid Partner Content | Why BioNTech, Moderna, and Novavax Stocks Are Sinking Today Jan 18 / MotleyFool.com - Paid Partner Content |
| Edge Wealth Management LLC Buys SPDR Biotech ETF, Salesforce. ... Jan 21 / GuruFocus News - Paid Partner Content | Here's Some Good News for Novavax That Investors Are Overlooking Jan 18 / MotleyFool.com - Paid Partner Content |
| Why Novavax Stock Tumbled on Thursday Jan 20 / MotleyFool.com - Paid Partner Content | 10 Top Stocks That Can Make You Richer in 2022 Jan 18 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 90.36 |
| Today’s open | 87.68 |
| Day’s range | 84.55 - 90.91 |
| Volume | 275,268 |
| Average volume (3 months) | 5,699,516 |
| Market cap | $6.4B |
Data as of 4:58pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | -31.99% |
| Earnings growth (this year) | -72.81% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +2,448.48% |
| P/E ratio | NM |
| Price/Sales | 13.49 |
| Price/Book | 9.57 |
Competitors
| ---- | ||
| NTLAIntellia Therapeutic... | -1.02 | -1.23% |
| NBIXNeurocrine Bioscienc... | +2.35 | +3.23% |
| ARWRArrowhead Pharmaceut... | -1.66 | -3.16% |
Data as of 4:00pm ET, 01/21/2022
Financials
| Next reporting date | February 28, 2022 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $475.6M |
| Annual profit (last year) | -$418.3M |
| Net profit margin | -87.94% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
